Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record

Variants in ABCB1 and CYP2C19 have been identified as predictors of cardiac events during clopidogrel therapy initiated after myocardial infarction (MI) or percutaneous coronary intervention (PCI). In addition, PON1 has recently been associated with stent thrombosis. The reported effects of these va...

詳細記述

保存先:
書誌詳細
主要な著者: Delaney, JT, Ramirez, AH, Bowton, E, Pulley, JM, Basford, MA, Schildcrout, JS, Shi, Y, Zink, R, Oetjens, M, Xu, H, Cleator, JH, Jahangir, E, Ritchie, MD, Masys, DR, Roden, DM, Crawford, DC, Denny, JC
フォーマット: Artigo
言語:Inglês
出版事項: 2011
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3621954/
https://ncbi.nlm.nih.gov/pubmed/22190063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2011.221
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料